EyePoint (EYPT) Depreciation and Depletion (2010 - 2025)
EyePoint (EYPT) reported Depreciation and Depletion of $489000.0 for Q4 2025, up 14.52% on a YoY basis from $427000.0 in Q4 2024, and down 15.1% sequentially from $576000.0 in Q3 2025.
EyePoint (EYPT) Depreciation and Depletion (2010 - 2025) Analysis & Trends
EyePoint (EYPT) has 16 years of Depreciation and Depletion data on file, last reported at $489000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion rose 14.52% year-over-year to $489000.0; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 40.0% YoY), and the FY2025 full-year result was $2.1 million, up 40.0% from the prior year.
- Depreciation and Depletion declined to $489000.0 in Q4 2025, from $576000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $576000.0 in Q3 2025 to a low of $70000.0 in Q2 2021.
- A 5-year average of $238550.0 and a median of $122500.0 in 2022 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion decreased 13.85% in 2023 and jumped 281.25% in 2024, its largest moves.
- Tracing EYPT's Depreciation and Depletion over 5 years: stood at $83000.0 in 2021, then soared by 56.63% to $130000.0 in 2022, then fell by 13.85% to $112000.0 in 2023, then jumped by 281.25% to $427000.0 in 2024, then advanced by 14.52% to $489000.0 in 2025.
- Business Quant data shows EYPT's Depreciation and Depletion at $489000.0 in Q4 2025, $576000.0 in Q3 2025, and $538000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 489,000.00 |
| Dec 31, 2025 | 489,000.00 |
| Sep 30, 2025 | 576,000.00 |
| Sep 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 538,000.00 |
| Jun 30, 2025 | 538,000.00 |
| Mar 31, 2025 | 497,000.00 |
| Mar 31, 2025 | 497,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 408,000.00 |
| Sep 30, 2024 | 408,000.00 |
| Jun 30, 2024 | 362,000.00 |
| Jun 30, 2024 | 362,000.00 |
| Mar 31, 2024 | 303,000.00 |
| Mar 31, 2024 | 303,000.00 |
| Dec 31, 2023 | 112,000.00 |
| Dec 31, 2023 | 112,000.00 |
| Sep 30, 2023 | 115,000.00 |
| Sep 30, 2023 | 115,000.00 |